APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Growth and Trends Forecast to 2032

2 January 2026119 pages

Choose your research edition.

Industry ResearchVaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Guangdong Yongshun Biological Pharmaceutical Co Ltd, Tiankang, Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health, Plec Bioengineering Co., Ltd., Jinyu Bio-Technology, Sinopharm and Guangdong Wens Dahuanong Biotechnology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Company

CNADC

Guangdong Yongshun Biological Pharmaceutical Co Ltd

Tiankang

Tianjin Ruipu Biological Technology Co., Ltd.

Qilu Animal Health

Plec Bioengineering Co., Ltd.

Jinyu Bio-Technology

Sinopharm

Guangdong Wens Dahuanong Biotechnology Co., Ltd.

Chengdu Tianbang Biological Products Co., Ltd.

Boehringer-Ingelheim

Zoetis

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type

Live Vaccine

Inactivated Vaccine

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application

Government Tender

Marketing

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccine Table 2. Major Company of Inactivated Vaccine Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type (2021-2026) Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type (2027-2032) Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 15. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 17. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (US$ Million) Table 24. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends Table 25. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers Table 26. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges Table 27. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints Table 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2021-2026) Table 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2021-2026) & (K Units) Table 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Company (2021-2026) Table 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Company Production Sites and Headquarters Table 35. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Company, Product Type & Application Table 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021-2026) & (K Units) Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2021-2026) Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2027-2032) & (K Units) Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2027-2032) Table 49. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 52. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application (2021-2026) Table 55. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application (2027-2032) Table 60. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 62. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 64. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (US$ Million) Table 71. CNADC Company Information Table 72. CNADC Business Overview Table 73. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 75. CNADC Recent Development Table 76. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information Table 77. Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview Table 78. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 80. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development Table 81. Tiankang Company Information Table 82. Tiankang Business Overview Table 83. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 85. Tiankang Recent Development Table 86. Tianjin Ruipu Biological Technology Co., Ltd. Company Information Table 87. Tianjin Ruipu Biological Technology Co., Ltd. Business Overview Table 88. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 90. Tianjin Ruipu Biological Technology Co., Ltd. Recent Development Table 91. Qilu Animal Health Company Information Table 92. Qilu Animal Health Business Overview Table 93. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 95. Qilu Animal Health Recent Development Table 96. Plec Bioengineering Co., Ltd. Company Information Table 97. Plec Bioengineering Co., Ltd. Business Overview Table 98. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 100. Plec Bioengineering Co., Ltd. Recent Development Table 101. Jinyu Bio-Technology Company Information Table 102. Jinyu Bio-Technology Business Overview Table 103. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 105. Jinyu Bio-Technology Recent Development Table 106. Sinopharm Company Information Table 107. Sinopharm Business Overview Table 108. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 110. Sinopharm Recent Development Table 111. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information Table 112. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview Table 113. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 115. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development Table 116. Chengdu Tianbang Biological Products Co., Ltd. Company Information Table 117. Chengdu Tianbang Biological Products Co., Ltd. Business Overview Table 118. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 120. Chengdu Tianbang Biological Products Co., Ltd. Recent Development Table 121. Boehringer-Ingelheim Company Information Table 122. Boehringer-Ingelheim Business Overview Table 123. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 125. Boehringer-Ingelheim Recent Development Table 126. Zoetis Company Information Table 127. Zoetis Business Overview Table 128. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 130. Zoetis Recent Development Table 131. Phibro Animal Health Company Information Table 132. Phibro Animal Health Business Overview Table 133. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 135. Phibro Animal Health Recent Development Table 136. MSD Animal Health Company Information Table 137. MSD Animal Health Business Overview Table 138. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 140. MSD Animal Health Recent Development Table 141. Komipharm Company Information Table 142. Komipharm Business Overview Table 143. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 145. Komipharm Recent Development Table 146. Ceva Company Information Table 147. Ceva Business Overview Table 148. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 150. Ceva Recent Development Table 151. CAVAC Company Information Table 152. CAVAC Business Overview Table 153. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 155. CAVAC Recent Development Table 156. Bioveta Company Information Table 157. Bioveta Business Overview Table 158. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 160. Bioveta Recent Development Table 161. Agrovet Company Information Table 162. Agrovet Business Overview Table 163. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 165. Agrovet Recent Development Table 166. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 168. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2026) Table 169. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Country (2027-2032) Table 171. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country (2021-2026) Table 174. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Country (2027-2032) Table 176. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 178. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2026) Table 179. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country (2021-2026) Table 184. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country (2021-2026) Table 194. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Country (2027-2032) Table 196. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 198. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2026) Table 199. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country (2021-2026) Table 204. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country (2021-2026) Table 214. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List Table 219. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Image Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2021-2032) & (K Units) Figure 5. Live Vaccine Image Figure 6. Global Live Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inactivated Vaccine Image Figure 8. Global Inactivated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Type 2025 VS 2032 Figure 11. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2025 Figure 12. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2025 Figure 13. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Tender Image Figure 24. Global Government Tender Sales YoY Growth (2021-2032) & (K Units) Figure 25. Marketing Image Figure 26. Global Marketing Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application 2025 VS 2032 Figure 29. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2025 Figure 30. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2025 Figure 31. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2025 Figure 39. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Vaccine f

Scope & coverage.

Types
  • Live Vaccine
  • Inactivated Vaccine
Applications
  • Government Tender
  • Marketing
Companies covered
  • CNADC
  • Guangdong Yongshun Biological Pharmaceutical Co Ltd
  • Tiankang
  • Tianjin Ruipu Biological Technology Co., Ltd.
  • Qilu Animal Health
  • Plec Bioengineering Co., Ltd.
  • Jinyu Bio-Technology
  • Sinopharm
  • Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  • Chengdu Tianbang Biological Products Co., Ltd.
  • Boehringer-Ingelheim
  • Zoetis
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Type
  6. 1.3.1 Live Vaccine
  7. 1.3.2 Inactivated Vaccine
  8. 1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  9. 1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
  2. 2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers
  3. 2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges
  4. 2.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2026)
  2. 3.2 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2021-2026)
  3. 3.3 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (2021-2026)
  4. 3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Company Production Sites & Headquarters
  6. 3.6 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Company, Product Type & Application
  7. 3.7 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Tier 1, Tier 2, and Tier 3
4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Regional Status and Outlook
  1. 4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Region
  3. 4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Region
  7. 4.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application
  1. 5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Application
  2. 5.1.1 Government Tender
  3. 5.1.2 Marketing
  4. 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  5. 5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CNADC
  2. 6.1.1 CNADC Company Information
  3. 6.1.2 CNADC Business Overview
  4. 6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  6. 6.1.5 CNADC Recent Developments
  7. 6.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd
  8. 6.2.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
  9. 6.2.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
  10. 6.2.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  12. 6.2.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments
  13. 6.3 Tiankang
  14. 6.3.1 Tiankang Company Information
  15. 6.3.2 Tiankang Business Overview
  16. 6.3.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  18. 6.3.5 Tiankang Recent Developments
  19. 6.4 Tianjin Ruipu Biological Technology Co., Ltd.
  20. 6.4.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
  21. 6.4.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
  22. 6.4.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  24. 6.4.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments
  25. 6.5 Qilu Animal Health
  26. 6.5.1 Qilu Animal Health Company Information
  27. 6.5.2 Qilu Animal Health Business Overview
  28. 6.5.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  30. 6.5.5 Qilu Animal Health Recent Developments
  31. 6.6 Plec Bioengineering Co., Ltd.
  32. 6.6.1 Plec Bioengineering Co., Ltd. Company Information
  33. 6.6.2 Plec Bioengineering Co., Ltd. Business Overview
  34. 6.6.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  36. 6.6.5 Plec Bioengineering Co., Ltd. Recent Developments
  37. 6.7 Jinyu Bio-Technology
  38. 6.7.1 Jinyu Bio-Technology Company Information
  39. 6.7.2 Jinyu Bio-Technology Business Overview
  40. 6.7.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  42. 6.7.5 Jinyu Bio-Technology Recent Developments
  43. 6.8 Sinopharm
  44. 6.8.1 Sinopharm Company Information
  45. 6.8.2 Sinopharm Business Overview
  46. 6.8.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  48. 6.8.5 Sinopharm Recent Developments
  49. 6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  50. 6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
  51. 6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
  52. 6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  54. 6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments
  55. 6.10 Chengdu Tianbang Biological Products Co., Ltd.
  56. 6.10.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
  57. 6.10.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
  58. 6.10.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  60. 6.10.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments
  61. 6.11 Boehringer-Ingelheim
  62. 6.11.1 Boehringer-Ingelheim Company Information
  63. 6.11.2 Boehringer-Ingelheim Business Overview
  64. 6.11.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  66. 6.11.5 Boehringer-Ingelheim Recent Developments
  67. 6.12 Zoetis
  68. 6.12.1 Zoetis Company Information
  69. 6.12.2 Zoetis Business Overview
  70. 6.12.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  72. 6.12.5 Zoetis Recent Developments
  73. 6.13 Phibro Animal Health
  74. 6.13.1 Phibro Animal Health Company Information
  75. 6.13.2 Phibro Animal Health Business Overview
  76. 6.13.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  78. 6.13.5 Phibro Animal Health Recent Developments
  79. 6.14 MSD Animal Health
  80. 6.14.1 MSD Animal Health Company Information
  81. 6.14.2 MSD Animal Health Business Overview
  82. 6.14.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  84. 6.14.5 MSD Animal Health Recent Developments
  85. 6.15 Komipharm
  86. 6.15.1 Komipharm Company Information
  87. 6.15.2 Komipharm Business Overview
  88. 6.15.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  90. 6.15.5 Komipharm Recent Developments
  91. 6.16 Ceva
  92. 6.16.1 Ceva Company Information
  93. 6.16.2 Ceva Business Overview
  94. 6.16.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  96. 6.16.5 Ceva Recent Developments
  97. 6.17 CAVAC
  98. 6.17.1 CAVAC Company Information
  99. 6.17.2 CAVAC Business Overview
  100. 6.17.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  102. 6.17.5 CAVAC Recent Developments
  103. 6.18 Bioveta
  104. 6.18.1 Bioveta Company Information
  105. 6.18.2 Bioveta Business Overview
  106. 6.18.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  108. 6.18.5 Bioveta Recent Developments
  109. 6.19 Agrovet
  110. 6.19.1 Agrovet Company Information
  111. 6.19.2 Agrovet Business Overview
  112. 6.19.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  114. 6.19.5 Agrovet Recent Developments
7 North America by Country
  1. 7.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  2. 7.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026)
  4. 7.1.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  6. 7.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026)
  8. 7.2.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  2. 8.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026)
  4. 8.1.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  6. 8.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  2. 9.1.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  6. 9.2.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  2. 10.1.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026)
  4. 10.1.3 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  6. 10.2.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026)
  8. 10.2.3 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  2. 11.1.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  6. 11.2.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain Analysis
  2. 12.1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process
  7. 12.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
  10. 12.2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst